167 related articles for article (PubMed ID: 15945298)
21. [Profibrotic effects of aldosterone].
Van Den Meiracker AH; Huizenga AT; Boomsma F
Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722
[TBL] [Abstract][Full Text] [Related]
22. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
[TBL] [Abstract][Full Text] [Related]
23. Use of aldosterone antagonists in resistant hypertension.
Calhoun DA
Prog Cardiovasc Dis; 2006; 48(6):387-96. PubMed ID: 16714158
[TBL] [Abstract][Full Text] [Related]
24. [Resistant hypertension].
Feldstein CA
Rev Med Chil; 2008 Apr; 136(4):528-38. PubMed ID: 18769797
[TBL] [Abstract][Full Text] [Related]
25. Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?
Coca SG; Perazella MA
Expert Rev Cardiovasc Ther; 2005 May; 3(3):497-512. PubMed ID: 15889977
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone, mineralocorticoid receptors, and vascular inflammation.
Fiebeler A; Muller DN; Shagdarsuren E; Luft FC
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):134-42. PubMed ID: 17293689
[TBL] [Abstract][Full Text] [Related]
27. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
28. The role of endothelin-1 in human hypertension.
Shreenivas S; Oparil S
Clin Hemorheol Microcirc; 2007; 37(1-2):157-78. PubMed ID: 17641406
[TBL] [Abstract][Full Text] [Related]
29. Resistant hypertension and aldosterone excess: new insights from ambulatory blood pressure monitoring.
Grassi G; Whitworth JA
J Hypertens; 2007 Oct; 25(10):2006-7. PubMed ID: 17885540
[No Abstract] [Full Text] [Related]
30. Role of aldosterone and angiotensin II in insulin resistance: an update.
Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
[TBL] [Abstract][Full Text] [Related]
31. Role of the renin-angiotensin system in vascular inflammation.
Marchesi C; Paradis P; Schiffrin EL
Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
[TBL] [Abstract][Full Text] [Related]
32. Hypertension and diabetes: role of the renin-angiotensin system.
Jandeleit-Dahm K; Cooper ME
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone receptor antagonism in heart failure.
Jennings DL; Kalus JS; O'Dell KM
Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
[TBL] [Abstract][Full Text] [Related]
34. A symposium: International update--the important role of aldosterone and aldosterone antagonism in cardiovascular medicine. Based on symposia held in Brussels, Belgium and Newport Beach, California.
Am J Cardiol; 1990 Jun; 65(23):1K-57K. PubMed ID: 2353664
[No Abstract] [Full Text] [Related]
35. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
36. Hypertensive heart disease: effects of lifestyle modifications and antihypertensive drug treatment.
Grandi AM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):617-25. PubMed ID: 15225120
[TBL] [Abstract][Full Text] [Related]
37. Aldosteronism and hypertension.
Calhoun DA
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
[TBL] [Abstract][Full Text] [Related]
38. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
39. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
40. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
Shah NC; Pringle S; Struthers A
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
